CAR T manufacturing
CAR T manufacturing

MilliporeSigma’s €300 Million Investment Fuels South Korea’s Bioproduction Boom
📢 MilliporeSigma invests €300 million in South Korea bioproduction site, creating 300 jobs and supporting biotech and pharma industries. 🏭💼🧪🧬

Game-Changing Cancer Immunotherapy Deal Unveiled
📰 Domain Therapeutics and Chime Biologics join forces to develop an anti-CCR8 antibody for cancer immunotherapy! 👥💉 Exciting times ahead! 🤝

Boost AAV Genome Production with RevIT Enhancer!
🚀 Boost AAV genome production with RevIT™ AAV Enhancer! 🧬💰 Increase titers, streamline workflows, and save costs in gene therapy manufacturing.

Revolutionary Partnership Expands Cell Therapy Development
📰 Multiply Labs and Thermo Fisher join forces to revolutionize cell therapy production! 💼🔬 Accelerating development and commercialization for patients. 🏭

AZ Accelerates Cell Therapy Production with FasTCAR: Faster Cheaper and Accessible
📢 AstraZeneca teams up with FasTCAR to fast-track cell therapy production, revolutionizing accessibility and affordability for patients. 🚀

Samsung Biologics and LegoChem unite to revolutionize cancer treatment
🔍 Samsung Biologics teams up with LegoChem to advance ADCs, combining antibodies and drugs to target cancer cells. 🔬 Collaboration leverages manufacturing expertise and ADC development technology for better cancer treatment options.

BioNTech and Autolus Join Forces for Revolutionary Cancer Treatments
📢 BioNTech and Autolus join forces in a $250m deal to revolutionize CAR-T cell therapies for cancer treatment. 💼🔬💪

Game-Changing Novo Catalent Deal Revolutionizes CGT Outsourcing
📢 Get ready for a game-changer! The Novo Catalent deal is about to shake up the CGT outsourcing space. 💥🧪💼

Regulatory Spotlight on Cleaning Validation in Biotech
📢 Cleaning validation is receiving increased attention from regulatory agencies in the biotechnology industry. 🧪🔬🏭🔍💼🔒






